Jasper Therapeutics (JSPR) Treasury Shares (2019 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Treasury Shares of $50894.0 for Q4 2025, down 90.75% year-over-year from $550000.0 in Q4 2024, and down 22.76% quarter-over-quarter from $65894.0 in Q3 2025.
Jasper Therapeutics (JSPR) Treasury Shares (2019 - 2025) Analysis & Trends
Jasper Therapeutics' Treasury Shares history runs 7 years deep, the most recent figure standing at $50894.0 for Q4 2025.
- In Q4 2025, Treasury Shares fell 90.75% year-over-year to $50894.0; the TTM figure through Dec 2025 stood at $50894.0 (down 90.75% YoY), while the FY2025 annual figure was $50894.0, down 90.75% from the prior year.
- Treasury Shares for Q4 2025 stood at $50894.0, down from $65894.0 in the prior quarter.
- The five-year high for Treasury Shares was $8.5 million in Q1 2021, with the low at $50894.0 in Q4 2025.
- The 5-year median for Treasury Shares is $550000.0 (2023), against an average of $1.7 million.
- The sharpest annual moves came in 2022 and 2023: Treasury Shares plunged 98.77% in 2022, then jumped 1079.77% in 2023.
- Jasper Therapeutics' Treasury Shares stood at $8.1 million in 2021, then plunged by 96.78% to $261729.0 in 2022, then surged by 110.14% to $550000.0 in 2023, then changed by 0.0% to $550000.0 in 2024, then plunged by 90.75% to $50894.0 in 2025.
- Business Quant data shows JSPR's Treasury Shares at $50894.0 in Q4 2025, $65894.0 in Q3 2025, and $65894.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 2.72 Mn |
| 10 | Jasper Therapeutics | 19.95 Mn | 19.95 Mn | - | 550,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50,894.00 |
| Dec 31, 2025 | 50,894.00 |
| Sep 30, 2025 | 65,894.00 |
| Sep 30, 2025 | 65,894.00 |
| Jun 30, 2025 | 65,894.00 |
| Jun 30, 2025 | 65,894.00 |
| Mar 31, 2025 | 65,894.00 |
| Mar 31, 2025 | 65,894.00 |
| Dec 31, 2024 | 550,000.00 |
| Dec 31, 2024 | 550,000.00 |
| Sep 30, 2024 | 550,000.00 |
| Sep 30, 2024 | 550,000.00 |
| Jun 30, 2024 | 550,000.00 |
| Jun 30, 2024 | 550,000.00 |
| Mar 31, 2024 | 550,000.00 |
| Mar 31, 2024 | 550,000.00 |
| Dec 31, 2023 | 550,000.00 |
| Dec 31, 2023 | 550,000.00 |
| Sep 30, 2023 | 5.50 Mn |
| Sep 30, 2023 | 5.50 Mn |